Beckman Coulter Dx

10/14/2026

News Announcement: Beckman Coulter Diagnostics Names Catherine Jennings as President

Experienced global healthcare leader to accelerate innovation and expand its impact for laboratories, clinicians and patients. BREA, Calif., Oct. 14, 2026 /PRNewswire/ -- Beckman Coulter...

09/22/2026

Scalability is not simply a function of maximum throughput specifications. Laboratories require clinical chemistry analyzers that can sustain high performance without sacrificing quality.

In this article for Medical Laboratory Observer, we dive into what will separate tomorrow’s high-performing laboratories and instruments from the rest, including:

📈 What distinguishes throughput from scalability—and how they impact each other

🔧 Why minimizing manual routine maintenance tasks matter more than you might think

🧪 What clinical chemistry innovations are available now or on the horizon to help

Read the full article to learn more: https://bit.ly/4Am5YRc

09/08/2026

Urinalysis demand continues to rise. How can you keep pace with rising volumes while maintaining the user confidence in the workflow?

Meet the new DxU 1800 Fully Automated Urinalysis System — designed to help you deliver standardized urinalysis results at scale.

Combining a new urine chemistry analyzer and consumables with proven microscopy technology, this system is designed to support both efficient workflows and timely patient care, so you can move from testing to decision-making with confidence.

Read more here: https://bit.ly/4gcfbCs

08/21/2026

New CLIA 2024 proficiency testing (PT) limits are narrowing acceptable error ranges for key hematology parameters 🔬. As these limits tighten, many laboratories are asking a practical question: can their analyzers consistently perform within these smaller margins?

In a recent article for SelectScience, our own Eric Pabon, MBA, Senior Manager, Global Product Marketing for Hematology, describes:

• How and why PT standards are evolving 📊
• What tighter limits mean for laboratories 🧪
• How Sigma metrics can help evaluate analytical performance 📈

Read the full article here 📖: https://bit.ly/4evebsd

08/17/2026

CAP TODAY recently hosted a roundtable discussion* about the current state — and exciting future — of urinalysis. Featuring our own Matthew N. Rhyner, PhD, MBA, vice president and managing director, hematology and urinalysis, the far-reaching conversation touched upon:

→ Strategies for improving efficiency in urinalysis ⚙️
→ Possibilities for AI to enhance reflex testing 🤖
→ Opportunities for optimizing the role of urinalysis in total lab automation 🔄
→ And much more ✨

Read the full article here 📖, then explore how Advantaged Workflows can help improve both the efficiency and clinical utility of urinalysis testing: https://bit.ly/4ewCkP5

* “Reaching for workflow efficiencies in urinalysis.” CAP TODAY, 2026. https://bit.ly/4ewCkP5

08/10/2026

Efficiency without clinical impact cannot support your greater purpose to care for patients. ❤️ And while clinical excellence is essential, if you can’t deliver it efficiently at scale, your impact will be limited.

💡This understanding led us to develop two philosophies that guide everything we do: and .

👉 Read our latest blog post to see how they are coming together to power the moments that matter at two healthcare organizations: https://bit.ly/3R13ju4

07/23/2026

News Release: Beckman Coulter Diagnostics Launches Fully Automated Urinalysis System to Meet Rising Testing Volumes

https://bit.ly/4fjuCtq

[auto]

07/07/2026

News Release: Beckman Coulter Diagnostics Expands Alzheimer's Portfolio with CE-Marked p-Tau217 Blood Test and New High-Specificity Research Assay

https://bit.ly/4wsR34T